Published in Clin Exp Immunol on September 01, 1987
Antireticulin antibody in systemic sclerosis. Ann Rheum Dis (1990) 1.40
A new antigen recognized by anti-liver-kidney-microsome antibody (LKMA). Clin Exp Immunol (1989) 0.93
Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes. Clin Exp Immunol (1993) 0.88
Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes. Clin Exp Immunol (1999) 0.80
Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality. Clin Exp Immunol (1988) 0.79
Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med (1968) 5.72
Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett (1985) 4.23
Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing gamma, epsilon and alpha genes. Nature (1982) 3.82
Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. J Immunol (1967) 3.37
Human immunoglobulins: classes, subclasses, genetic variants, and idiotypes. Adv Immunol (1973) 3.25
The interaction between human monocytes and red cells. Specificity for IgG subclasses and IgG fragments. J Exp Med (1970) 2.05
HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology (1980) 1.65
Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J (1974) 1.64
Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med (1985) 1.52
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology (1974) 1.50
Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol (1981) 1.43
IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases. Immunology (1984) 1.37
The IgG subclass responses of human lymphocytes to B-cell activators. Immunology (1983) 1.35
The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol (1984) 1.34
Predominance of IgG3 subclass in primary cirrhosis. Br Med J (Clin Res Ed) (1983) 1.08
Autoimmunity in liver disease. Clin Sci (Lond) (1984) 1.04
Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis. Lancet (1985) 0.95
Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM). Clin Exp Immunol (1984) 0.91
Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet (1990) 4.57
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med (2000) 3.78
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet (1998) 3.33
Late referral for biliary atresia--missed opportunities for effective surgery. Lancet (1989) 3.27
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol (1982) 3.09
Extrahepatic biliary atresia versus neonatal hepatitis. Review of 137 prospectively investigated infants. Arch Dis Child (1976) 2.67
A test of the nature of cosmic acceleration using galaxy redshift distortions. Nature (2008) 2.65
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 2.62
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 2.45
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41
1 -Antitrypsin deficiency and neonatal hepatitis. Br Med J (1972) 2.40
Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr (1993) 2.32
Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31
Results of surgical treatment for extrahepatic biliary atresia in United Kingdom 1980-2. Survey conducted on behalf of the British Paediatric Association Gastroenterology Group and the British Association of Paediatric Surgeons. Br Med J (Clin Res Ed) (1985) 2.29
Congenital hepatoportal arteriovenous fistula. Surgery (1995) 2.14
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem (1988) 2.01
Autoimmune hepatitis in childhood: a 20-year experience. Hepatology (1997) 1.97
Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr (1993) 1.96
Liver transplantation in 100 children: Cambridge and King's College Hospital series. BMJ (1992) 1.90
Hepatitis syndrome in infancy--an epidemiological survey with 10 year follow up. Arch Dis Child (1985) 1.89
The changing clinical pattern of Reye's syndrome 1982-1990. Arch Dis Child (1996) 1.84
Fetal ascites: an unusual presentation of Niemann-Pick disease type C. Arch Dis Child (1989) 1.77
Biliary atresia: the King's College Hospital experience (1974-1995) J Pediatr Surg (1997) 1.75
Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. J Am Coll Cardiol (2001) 1.63
Jaundice at 14 days of age: exclude biliary atresia. Arch Dis Child (1991) 1.61
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology (2001) 1.59
Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg (2001) 1.55
Increased hepatic copper concentration in Indian childhood cirrhosis. Lancet (1979) 1.54
Fulminant hepatic failure in childhood: an analysis of 31 cases. Arch Dis Child (1980) 1.53
T cell activation and disease severity in HIV infection. Clin Exp Immunol (1993) 1.53
Reye's syndrome: 20 years on. Br Med J (Clin Res Ed) (1983) 1.50
Choledochal cysts: lessons from a 20 year experience. Arch Dis Child (1995) 1.48
Neonatal hepatitis syndrome and alpha-1-antitrypsin deficiency: an epidemiological study in south-east England. Postgrad Med J (1974) 1.48
Orcein-positive liver deposits in Indian childhood cirrhosis. Lancet (1978) 1.47
Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol (1979) 1.47
Results of surgery in 88 consecutive cases of extrahepatic biliary atresia. J R Soc Med (1982) 1.45
Molecular basis, clinical consequences and diagnosis of alpha-1 antitrypsin deficiency. Ann Clin Biochem (1997) 1.44
Halothane-induced acute liver failure: continuing occurrence and use of liver transplantation. Eur J Gastroenterol Hepatol (1998) 1.41
Biliary atresia splenic malformation syndrome: an etiologic and prognostic subgroup. Surgery (1993) 1.41
Antireticulin antibody in systemic sclerosis. Ann Rheum Dis (1990) 1.40
Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet (1991) 1.38
Shared amino acid sequences between glutamic acid decarboxylase 65 and 67 and alpha-2-macroglobulin. A focus for cross-reactive autoantibodies? Diabetologia (1995) 1.38
Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J Inherit Metab Dis (2002) 1.37
Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity. Clin Exp Immunol (1982) 1.37
The prelaparotomy diagnosis of extrahepatic biliary atresia. Arch Dis Child (1983) 1.36
Extrahepatic biliary atresia. Recent developments in management. Arch Dis Child (1977) 1.35
Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes. Lancet (1984) 1.34
Congenital microcephaly with hiatus hernia and nephrotic syndrome in two sibs. J Med Genet (1968) 1.33
De-novo autoimmune hepatitis after liver transplantation. Lancet (1998) 1.30
Assessment of injection sclerotherapy in the management of 152 children with oesophageal varices. Br J Surg (1988) 1.28
Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis. Gut (1981) 1.27
Ocular abnormalities in Alagille syndrome. Ophthalmology (1999) 1.25
Virus, liver and autoimmunity. Dig Liver Dis (2001) 1.24
Bovine salmonellosis in England and Wales. Br Vet J (1971) 1.24
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther (2003) 1.23
Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis. Clin Exp Immunol (1987) 1.23
HCV and autoimmunity. Curr Pharm Des (2008) 1.22
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia (1996) 1.21
Developmental effects on liver D-glucuronolactone dehydrogenase levels and on D-glucaric acid excretion in urine; hormonal effects on D-glucaric acid excretion in urine. J Endocrinol (1968) 1.21
Seamless management of biliary atresia in England and Wales (1999-2002). Lancet (2004) 1.19
Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology (1994) 1.19
Crigler-Najjar syndrome types I and II. Clinical experience--King's College Hospital 1972-1978. Phenobarbitone, phototherapy and liver transplantation. Mol Aspects Med (1987) 1.19
Outcome of liver disease associated with alpha 1 antitrypsin deficiency (PiZ). Implications for genetic counselling and antenatal diagnosis. Arch Dis Child (1983) 1.17
Wilson's disease: clinical presentation and use of prognostic index. Gut (1986) 1.16
Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology (1992) 1.16
Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.15
Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes? Br Med J (Clin Res Ed) (1983) 1.15
IgM reduction in systemic lupus erythematosus. Arthritis Rheum (1988) 1.15
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity. J Infect Dis (1990) 1.14
Hepatic damage after exposure to halothane in medical personnel. Br J Anaesth (1981) 1.13
Clinical application of a new nephelometric technique to measure complement activation. J Clin Pathol (1983) 1.13
Extrahepatic biliary atresia: preoperative assessment and surgical results in 47 consecutive cases. Arch Dis Child (1980) 1.12
Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia. Lancet (1978) 1.12
Syndromic paucity of the intrahepatic bile ducts: diagnostic difficulty; severe morbidity throughout early childhood. J Pediatr Gastroenterol Nutr (1988) 1.11
Immune changes associated with insulin dependent diabetes may remit without causing the disease: a study in identical twins. Br Med J (Clin Res Ed) (1986) 1.11
Hepatic artery resistance index can predict early death in children with biliary atresia. Liver Transpl Surg (1997) 1.10